Language Menu ⇨

THANK YOU!

SITE MAP

19 speakers - 9 countries

International Conference

Proceedings of the world HSCT conference in Moscow. Sharing the Experience in applying the HSCT treatment for AID. Profiles and reports of 19 speakers from 9 countries.

General Information

General information about HSCT treatment for Patients with Multiple Sclerosis

Stages of Treatment

Description of HSCT treatment stages in Moscow Hospital, Russia.

General Advantages

Advantages of HSCT Treatment for Multiple Sclerosis Patients in Moscow, Russia.

Medications cancellation

Before Treatment

Patient should stop taking immunomodulating drugs in 3-6 months before admission

Application for MS

The following questionnaire is required to define whether HSCT is a meaningful and safe treatment option.

Vincoli di salute

Elenco delle indicazioni mediche per il trattamento del trapianto di cellule staminali emopoietiche per malattie autoimmuni

Step-by-step guide

Admission to the Hospital

This page is intended to help patients who have already completed a questionnaire and have been approved for treatment.

Dr. Denis Fedorenko

Dr. Denis Fedorenko

The Leading Hematologist of Russia, Doctor of Medical Sciences, Professor of the Department of Hematology and Cellular Therapy

19 speakers - 9 countries

International Conference

Proceedings of the world HSCT conference in Moscow. Sharing the Experience in applying the HSCT treatment for AID. Profiles and reports of 19 speakers from 9 countries.

Coming soon new webinar with PhD, MD, Dr. Denis Fedorenko